FDA Approval Sends Shares on a Tear
25 Septiembre 2023 - 9:30AM
AllPennyStocks.com
The morning opened up on a high note for this dually-listed
company as it announced U.S. Food and Drug Administration (FDA)
approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501
)....
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (TSX:APLI)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Appili Therapeutics (TSX:APLI)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024